共 37 条
[21]
Marsden J., Eastwood B., Bradbury C., Dale-Perera A., Farrell M., Hammond P., Knight J., Randhawa K., Wright C., Effectiveness of community treatments for heroin and crack cocaine addiction in england: A prospective, intreatment cohort study, Lancet, 374, pp. 1262-1270, (2009)
[22]
Mattick R.P., Breen C., Kimber J., Davoli M., Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence, Cochrane Database Syst Rev, (2009)
[23]
McCance-Katz E.F., Jatlow P., Rainey P.M., Effect of cocaine use on methadone pharmacokinetics in humans, Am J Addict, 19, pp. 47-52, (2010)
[24]
Mucha R.F., Iversen S.D., Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: A procedural examination, Psychopharmacology, 82, 3, pp. 241-247, (1984)
[25]
Peles E., Schreiber S., Adelson M., Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (mmt) clinic in israel, Drug Alcohol Depend, 82, pp. 211-217, (2006)
[26]
Pierce T.L., Hope W., Raper C., The induction and quantitation of methadone dependence in the rat, Journal of Pharmacological and Toxicological Methods, 36, 3, pp. 137-146, (1996)
[27]
Popik P., Danysz W., Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine, Journal of Pharmacology and Experimental Therapeutics, 280, 2, pp. 854-865, (1997)
[28]
Popik P., Kozela E., Wrobel M., Wozniak K.M., Slusher B.S., Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase ii (gcp ii, naaladase) inhibitor, 2-pmpa, Neuropsychopharmacology, 28, pp. 457-467, (2003)
[29]
Robinson T.E., Berridge K.C., Incentive-sensitization and addiction, Addiction, 96, 1, pp. 103-114, (2001)
[30]
Shippenberg T.S., Lefevour A., Thompson A.C., Sensitization to the conditioned rewarding effects of morphine and cocaine: Differential effects of the κ-opioid receptor agonist U69593, European Journal of Pharmacology, 345, 1, pp. 27-34, (1998)